CXCL16 and central nervous system cancer: The hypothesis that CXCL16 released from tumor cells acts in an autocrine/paracrine way to promote tumor progression is further confirmed by the significant reduction in tumor volume, proliferation, and infiltration in mice bearing glioma cells silenced for CXCL16.